← Back to Search

Other

Light + Online Therapy for ADHD

N/A
Recruiting
Led By Emily J Ricketts, Ph.D.
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 weeks
Awards & highlights

Study Summary

This trial will test if a combination of light therapy and online therapy can help teens with ADHD and poor sleep schedules.

Who is the study for?
This trial is for adolescents aged 14-17 with ADHD-combined type and delayed sleep-wake schedules. They must have trouble sleeping early, difficulty waking up, significant ADHD severity, an evening chronotype, and moderate to severe global functioning impairment. Participants need to be attending school during the study and fluent in English.Check my eligibility
What is being tested?
The study tests flashed light therapy alone for two weeks followed by a combination of daily light therapy with weekly videoconference-delivered cognitive behavioral therapy sessions targeting circadian rhythms and sleep over four weeks.See study design
What are the potential side effects?
Potential side effects are not explicitly listed but may include discomfort or changes in sleep patterns due to the light therapy. Cognitive behavioral therapy typically does not have physical side effects but can sometimes cause temporary increases in distress.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Treatment Feasibility: Child-reported
Treatment Feasibility: Parent-reported
Treatment Tolerability: Attrition
+1 more
Secondary outcome measures
Assessment Tolerability: Child-reported
Assessment Tolerability: Parent-reported
Treatment Sensitivity of Circadian Phase
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1) Flashed Light Therapy, 2) Flashed Light Therapy with Cognitive Behavioral TherapyExperimental Treatment2 Interventions
Treatment Phase 1 (2 weeks duration): light flashes administered for 60 minutes daily beginning 75 minutes prior to the participant's average morning wake time and ending 15 minutes before average morning wake time. Treatment Phase 2 (4 weeks duration): will begin immediately following phase 1 and involve daily light flashes (as described above) combined with weekly 50-minute videoconference-delivered cognitive-behavioral therapy.

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,276,847 Total Patients Enrolled
11 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
1,116 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Emily J Ricketts, Ph.D.Principal InvestigatorUniversity of California, Los Angeles

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to register for this experiment?

"The requirements to be accepted in this trial are having ADHD and being between the ages of 14 and 17. Up to four patients can join."

Answered by AI

Is the current age eligibility for this trial limited to persons under sixty?

"In order to participate in this trial, applicants must be aged between 14 and 17. 90 participants have been recruited from the eligible cohort below 18 years old, while 29 candidates are over 65."

Answered by AI

Does this study still accept new participants?

"According to information published on clinicaltrials.gov, this trial is actively recruiting participants. The study was first announced on September 20th 2023 and has most recently been updated as of the 6th of Septemeber in the same year."

Answered by AI

What results are researchers hoping to achieve from this trial?

"This 7-week clinical trial is primarily aimed at determining the feasibility of treatment as reported by parents. Secondary objectives include establishing tolerance levels based on parent ratings, circadian phase sensitivity to treatments, and sleep onset time sensitity to treatments as measured with actigraphy."

Answered by AI

What is the upper capacity of participants for this investigation?

"Affirmative. According to data available on clinicaltrials.gov, this medical trial is actively recruiting candidates and was initially posted on September 20th of 2023 with the most recent update occurring on September 6th of the same year. The study requires 4 participants from one site for admittance."

Answered by AI

Who else is applying?

What site did they apply to?
Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Flashed Light Therapy for Adolescents With ADHD and Delayed Sleep Timing
Emily J. Ricketts, PhD 2023. "Flashed Light Therapy for Adolescents With ADHD and Delayed Sleep Timing". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06036420.
All > Adhd
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top